245 related articles for article (PubMed ID: 28586916)
21. EPO protects Müller cell under high glucose state through BDNF/TrkB pathway.
Wang P; Xia F
Int J Clin Exp Pathol; 2015; 8(7):8083-90. PubMed ID: 26339375
[TBL] [Abstract][Full Text] [Related]
22. High glucose-induced downregulation of connexin 30.2 promotes retinal vascular lesions: implications for diabetic retinopathy.
Manasson J; Tien T; Moore C; Kumar NM; Roy S
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2361-6. PubMed ID: 23385797
[TBL] [Abstract][Full Text] [Related]
23. Diabetes Impairs the Aldehyde Detoxifying Capacity of the Retina.
McDowell RE; McGahon MK; Augustine J; Chen M; McGeown JG; Curtis TM
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4762-71. PubMed ID: 27618414
[TBL] [Abstract][Full Text] [Related]
24. Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema.
Kida T; Oku H; Horie T; Fukumoto M; Okuda Y; Morishita S; Ikeda T
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1149-1157. PubMed ID: 28303331
[TBL] [Abstract][Full Text] [Related]
25. TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy.
Ao H; Li H; Zhao X; Liu B; Lu L
Life Sci; 2021 Feb; 267():118988. PubMed ID: 33412212
[TBL] [Abstract][Full Text] [Related]
26. Astragalus polysaccharides suppresses high glucose-induced metabolic memory in retinal pigment epithelial cells through inhibiting mitochondrial dysfunction-induced apoptosis by regulating miR-195.
Liu P; Peng QH; Tong P; Li WJ
Mol Med; 2019 May; 25(1):21. PubMed ID: 31117931
[TBL] [Abstract][Full Text] [Related]
27. PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Müller cells during diabetic retinopathy.
Guo Y; Cang X; Zhu L; Zhu M; Li A; Wang Z; Zhang Y; Wang X; Song E
Exp Eye Res; 2021 Sep; 210():108703. PubMed ID: 34280391
[TBL] [Abstract][Full Text] [Related]
28. High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy.
Chronopoulos A; Trudeau K; Roy S; Huang H; Vinores SA; Roy S
Curr Eye Res; 2011 Aug; 36(8):747-53. PubMed ID: 21780924
[TBL] [Abstract][Full Text] [Related]
29. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
30. Edaravone prevents high glucose-induced injury in retinal Müller cells through thioredoxin1 and the PGC-1α/NRF1/TFAM pathway.
Yin J; Chen X
Pharm Biol; 2021 Dec; 59(1):1233-1244. PubMed ID: 34506218
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal marker expression is elevated in Müller cells exposed to high glucose and in animal models of diabetic retinopathy.
Zhou T; Che D; Lan Y; Fang Z; Xie J; Gong H; Li C; Feng J; Hong H; Qi W; Ma C; Yang Z; Cai W; Zhong J; Ma J; Yang X; Gao G
Oncotarget; 2017 Jan; 8(3):4582-4594. PubMed ID: 27999189
[TBL] [Abstract][Full Text] [Related]
32. Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine.
McDowell RE; Barabas P; Augustine J; Chevallier O; McCarron P; Chen M; McGeown JG; Curtis TM
Diabetologia; 2018 Dec; 61(12):2654-2667. PubMed ID: 30112688
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol Prevents Retinal Dysfunction by Regulating Glutamate Transporters, Glutamine Synthetase Expression and Activity in Diabetic Retina.
Zeng K; Yang N; Wang D; Li S; Ming J; Wang J; Yu X; Song Y; Zhou X; Yang Y
Neurochem Res; 2016 May; 41(5):1050-64. PubMed ID: 26677078
[TBL] [Abstract][Full Text] [Related]
34. Activation of retinal Müller cells in response to glucose variability.
Picconi F; Parravano M; Sciarretta F; Fulci C; Nali M; Frontoni S; Varano M; Caccuri AM
Endocrine; 2019 Sep; 65(3):542-549. PubMed ID: 31327157
[TBL] [Abstract][Full Text] [Related]
35. High Glucose Increases Binding of Lysyl Oxidase to Extracellular Matrix Proteins: Implications for Diabetic Retinopathy.
Nguyen NH; Kim D; Roy S
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):40. PubMed ID: 32340032
[TBL] [Abstract][Full Text] [Related]
36. Involvement of P2X
Xue B; Xie Y; Xue Y; Hu N; Zhang G; Guan H; Ji M
Exp Eye Res; 2016 Dec; 153():42-50. PubMed ID: 27720859
[TBL] [Abstract][Full Text] [Related]
37. IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.
Qiu AW; Bian Z; Mao PA; Liu QH
Exp Mol Med; 2016 Dec; 48(12):e280. PubMed ID: 27980343
[TBL] [Abstract][Full Text] [Related]
38. The impact of sestrin2 on reactive oxygen species in diabetic retinopathy.
Yang X; Wu X
Cell Biochem Funct; 2024 Jun; 42(4):e4024. PubMed ID: 38666564
[TBL] [Abstract][Full Text] [Related]
39. Exploring the role of Müller cells-derived exosomes in diabetic retinopathy.
Gad MS; Elsherbiny NM; El-Bassouny DR; Omar NM; Mahmoud SM; Al-Shabrawey M; Tawfik A
Microvasc Res; 2024 Jul; 154():104695. PubMed ID: 38723843
[TBL] [Abstract][Full Text] [Related]
40. Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway.
Wu C; Xu K; Liu W; Liu A; Liang H; Li Q; Feng Z; Yang Y; Ding J; Zhang T; Liu Y; Liu X; Zuo Z
Curr Eye Res; 2022 Jan; 47(1):135-142. PubMed ID: 34133251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
